| Alicia Vatter, FNP-C | |
|
750 Reservoir Ave, Cranston, RI 02910-4423 | |
| (401) 943-0761 | |
| (401) 943-5737 |
| Full Name | Alicia Vatter |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 750 Reservoir Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265107023 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN02781 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Derm And Cosmetic Center, Inc | 6709004484 | 6 |
News Archive
Doctors are beginning the first test in the United States of a vaccine designed to protect people against one form of bird flu should an outbreak of the virus occur in humans. While the vaccine under study is not designed to protect against the precise bird-flu virus causing the current outbreak in poultry and in people, scientists will learn whether it protects against another strain of the virus that infects birds and people.
Researchers from the Universitat Autònoma de Barcelona, in collaboration with the University of Oviedo and the Biomedical Research Networking Centre in Mental Health, have designed a test which can help determine the cognitive capacities of patients with schizophrenia.
The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients. Using an insect virus, the team of researchers successfully inserted a therapeutic gene into a safe site in the DNA of human embryonic stem cells without compromising the functionality of the engineered cells.
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.
› Verified 4 days ago
| Entity Name | Coastal Derm & Cosmetic Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528487683 PECOS PAC ID: 6709004484 Enrollment ID: O20140821000021 |
News Archive
Doctors are beginning the first test in the United States of a vaccine designed to protect people against one form of bird flu should an outbreak of the virus occur in humans. While the vaccine under study is not designed to protect against the precise bird-flu virus causing the current outbreak in poultry and in people, scientists will learn whether it protects against another strain of the virus that infects birds and people.
Researchers from the Universitat Autònoma de Barcelona, in collaboration with the University of Oviedo and the Biomedical Research Networking Centre in Mental Health, have designed a test which can help determine the cognitive capacities of patients with schizophrenia.
The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients. Using an insect virus, the team of researchers successfully inserted a therapeutic gene into a safe site in the DNA of human embryonic stem cells without compromising the functionality of the engineered cells.
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Vatter, FNP-C 750 Reservoir Ave, Cranston, RI 02910-4423 Ph: (401) 943-0761 | Alicia Vatter, FNP-C 750 Reservoir Ave, Cranston, RI 02910-4423 Ph: (401) 943-0761 |
News Archive
Doctors are beginning the first test in the United States of a vaccine designed to protect people against one form of bird flu should an outbreak of the virus occur in humans. While the vaccine under study is not designed to protect against the precise bird-flu virus causing the current outbreak in poultry and in people, scientists will learn whether it protects against another strain of the virus that infects birds and people.
Researchers from the Universitat Autònoma de Barcelona, in collaboration with the University of Oviedo and the Biomedical Research Networking Centre in Mental Health, have designed a test which can help determine the cognitive capacities of patients with schizophrenia.
The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients. Using an insect virus, the team of researchers successfully inserted a therapeutic gene into a safe site in the DNA of human embryonic stem cells without compromising the functionality of the engineered cells.
Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and ribavirin has proven as effective in treating chronic Hepatitis C virus infection (HCV) as telaprevir with interferon and ribavirin, the standard of care in developing countries.
A new study published on the preprint server medRxiv* in May 2020 reports the beneficial effects of the monoclonal antibody sarilumab in severe COVID-19 pneumonia.
› Verified 4 days ago
Jillian L. Degraide, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 725 Reservoir Ave, Cranston, RI 02910 Phone: 401-829-4446 | |
Dr. Moira L Long, DNP, MSN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 311 Doric Ave, Cranston, RI 02910 Phone: 401-467-9610 | |
Kathleen Patricia Natareno, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1960 Cranston St, Cranston, RI 02920 Phone: 401-946-0494 | |
Jackeline Paola Ramos, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2220 Plainfield Pike, Cranston, RI 02921 Phone: 401-585-8500 | |
Mrs. Jennifer Nitanya Barlow, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1170 Pontiac Ave, Cranston, RI 02920 Phone: 401-895-9937 Fax: 401-296-3998 | |
Anita Oforiwaa Obeng, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 Reservoir Ave, Cranston, RI 02920 Phone: 401-259-0340 | |
Elizabeth Pereira, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2000 Chapel View Blvd, Cranston, RI 02920 Phone: 401-400-8414 |